Your browser doesn't support javascript.
loading
Robust generation of neutralising antibodies against Omicron variants following bivalent mRNA booster vaccine in elderly people aged >80 years.
Parry, Helen; Bruton, Rachel; Uwenedi, Grace; Roberts, Thomas; Sylla, Panagiota; Cook, Jonathan; Elzaidi, Ahmed; Lau, May; Drury, Tamsin; Bray, Alexander; Mallick, Soumyajit; Spencer, Katie; Bentley, Christopher; McIlroy, Graham; Scott, Sam; Logan, Nicola; Zuo, Jianmin; Willett, Brian; Moss, Paul.
Afiliación
  • Parry H; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
  • Bruton R; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
  • Uwenedi G; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
  • Roberts T; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
  • Sylla P; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
  • Cook J; Centre for Statistics in Medicine, University of Oxford, Nuffield Orthopaedic Centre, Windmill Road, Headington, Oxford OX3 7LD, UK.
  • Elzaidi A; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
  • Lau M; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
  • Drury T; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
  • Bray A; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
  • Mallick S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK; University Hospitals Birmingham, Edgbaston, Birmingham, UK; Centre for Statistics in Medicine, University of Oxford, Nuffield Orthopaedic Centre, Windmill Road, Headington, Oxford OX3 7LD, UK; MRC-University
  • Spencer K; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
  • Bentley C; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
  • McIlroy G; University Hospitals Birmingham, Edgbaston, Birmingham, UK.
  • Scott S; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK.
  • Logan N; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK.
  • Zuo J; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
  • Willett B; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK.
  • Moss P; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK. Electronic address: p.moss@bham.ac.uk.
J Infect ; 88(1): 48-50, 2024 Jan.
Article en En | MEDLINE | ID: mdl-37660756
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vacunas / Anticuerpos Neutralizantes Límite: Aged / Humans Idioma: En Revista: J Infect Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vacunas / Anticuerpos Neutralizantes Límite: Aged / Humans Idioma: En Revista: J Infect Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido